Home » Stocks » DRMA

Dermata Therapeutics, Inc. (DRMA)

Dermata Therapeutics will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet
Market Cap n/a
Revenue (ttm) n/a
Net Income (ttm) -4.12M
Shares Out n/a
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day n/a
Last Price n/a
Previous Close n/a
Change ($) n/a
Change (%) n/a
Day's Open n/a
Day's Range n/a
Day's Volume n/a
52-Week Range n/a

News

Dermata Therapeutics, Inc. has filed to go public with an IPO on the NASDAQ.

1 week ago - SEC

About DRMA

Dermata Therapeutics is a clinical-stage biotechnology company focusing on the treatment of medical and aesthetic skin conditions. Our Spongilla technology platform is based on the use of a naturally growing freshwater sponge, Spongilla lacustris, or Spongilla. Traditionally, locals would harvest the sponge to be used as a folk medicine to treat various inflammatory ailments, but research has been conducted to evaluate the use of Spongilla for the possible treatment of various skin diseases and aesthetic conditions. Our lead product candidate, ... [Read more...]

Industry
Pharmaceutical Preparations
IPO Date
Pending
CEO
Gerald T. Proehl
Employees
7
Stock Exchange
NASDAQ
Ticker Symbol
DRMA
Full Company Profile

Financial Performance

Financial Statements